Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Upcoming events milestones and dates

<< Previous

Bullboard Posts

Next >>

Post by Golddetectoron Jan 14, 2022 8:48am

334 Views

Post# 34316068

Upcoming events milestones and dates

Ppl who wants to skip the trash talk here and want to jump to something useful below is the link to tetra latest presentation dated December 2021. Also below Guy last presentation video in the small cap conference Gl longs

https://s24.q4cdn.com/136309390/files/doc_presentation/2021/12/Tetra-Bio-Pharma-Corporate-Presentation-December-2021.pdf